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Summary 
Huntington's disease (HD) is an incurable neuropsychi- 
atric disease associated with CAG repeat expansion 
within a widely expressed gene that causes selective 
neuronal death. To understand its normal function, we 
have created a targeted disruption in exon 5 of Hdh 
(HdhexS), the m urine homolog of the HD gene. Homozy- 
gotes die before embryonic day 8,5, initiate gastrula- 
tion, but do not proceed to the formation of somites 
or to organogenesis. Mice heterozygous for the Hdh "x5 
mutation display increased motor activity and cogni- 
tive deficits. Neuropathological assessment of two 
heterozygous mice shows significant neuronal loss in 
the subthalamic nucleus. These studies show that the 
HD gene is essential for postimplantation develop- 
ment and that it may play an important role in normal 
functioning of the basal ganglia. 
Introduction 
Huntington's disease (HD) is a devastating neurological 
disease associated with chorea, cognitive deficit, psychi- 
atric disturbances, and inexorable progression to death, 
typically 10-15 years after onset. It usually manifests in 
midlife, affects approximately 1 in 10,000 individuals (Hay- 
den, 1981), and results in selective neuronal loss that is 
most prominent in the striatum and basal ganglia (Vonsat- 
tel et al., 1985). 
The HD gene (IT15) (Huntington's Disease Collaborative 
Research Group, 1993)is ubiquitously expressed (Strong 
et al., 1993; Li et al., 1993) and conserved across a wide 
range of species (Lin et al., 1994). Structural analysis of 
its promoter region is consistent with its being a house- 
keeping gene (Lin et al., 1995). IT15 encompasses 67 ex- 
one, spans over 200 kb (Ambrose et al., 1994), and is 
associated with two transcripts of 10.3 kb and 13.6 kb, 
differing with respect to their 3' untranslated regions (Lin 
et al., 1993). In addition, IT15 encompasses a highly poly- 
morphic CAG repeat that varies in number from eight to 35 
in normal individuals (Kremer et al., 1994). CAG expansion 
beyond 36 CAG repeats is seen in persons with HD. A 
similar mutational mechanism is associated with five other 
neurodegenerative diseases that are also associated with 
expansions of CAG repeats within their coding regions 
(Willems, 1994). Lack of homology to other genes or to any 
obvious functional domains has meant that the function of 
these genes has hitherto remained a mystery. In particu- 
lar, the question of how these widely expressed gene s 
cause selective neuronal death remains unanswered. 
We have previously mapped (Nasir et al., 1994), cloned, 
and sequenced (Lin et al., 1994) Hdh, the murine homolog 
of the HD gene, which shares a high degree of homology 
with its human homolog but differs with respect to length 
of its CAG repeat. In mouse there are only seven CAG 
repeats that are interrupted at the third triplet with CAA. 
To gain further insights into the physiological role of the 
HD gene during growth and development, we generated 
mice with a targeted disruption of the HD gene. We have 
created null mutants by inserting the neomycin (neo) gene 
cassette into exon 5 of Hdh (HdheXS). We have demon- 
strated that mice derived from three independently tar- 
geted embryonic stem (ES) cell lines do not survive to 
term and suffer early postimplantation embryonic lethality. 
Heterozygotes for this mutation have increased motor ac- 
tivity and cognitive deficits associated with neuronal loss 
in the subthalamic nucleus of the basal ganglia. These 
data show that the HD gene is essential for normal embry- 
onic development and suggest a role for this gene in nor- 
mal development of the basal ganglia. 
Results 
Targeted Disruption of the Hdh Gene 
A genomic library from the 129/Sv mouse strain was 
screened with a murine cDNA clone encompassing exon 
5 (Lin et al., 1994). Several clones were recovered and 
restriction mapped in detail, and exon-intron boundaries 
were sequenced (Lin et al., 1995). 
To create a disruption in exon 5 of the Hdh gene (Hdhe~, 
we generated the targeting construct pHdhNeo6 (Figure 
1A) by deleting approximately half of exon 5 plus intron 
4 sequences and replacing them with a PGKneobpA cas- 
sette. Disruption of murine exon 5 results in stop codons 
in all reading frames. 
Screening for Homologous Recombination 
A total of 360 G418-resistant colonies were picked and 
screened by polymerase chain reaction (PCR) using aneo- 
specific primer (P7) and a primer (P6) flanking the integra- 
tion site (Figure 1A). The expected size fragment (1.3 kb) 
was detected in five pools (Figure 1B). Individual clones 
corresponding to each positive pool were separately 
screened by PCR. Six clones were identified, indicating 
a targeting frequency of 1 in 60 G418-resistant clones (6 
of 360). 
Three independently targeted ES cell lines were estab- 
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Figure 1. Targeted Disruption of the Hdh Gene 
(A) The targeting vector and its relationship to the wild-type allele are 
depicted. The relative positions of exons 4 and 5 are as indicated. The 
targeting vector was generated by replacing a 600 bp Espl fragment 
encompassing a portion of exon 5 plus part of intron 4 with a 
PGKneobpa cassette (see Experimental Procedures). The locations 
of the PCR primers (P6 and P7) used to screen for homologous recom- 
bination and the genomic probe used to confirm this are also given. 
Note that the insertion of the neocassette at exon 5 leads to an increase 
in size of the Hindlll and EcoRI fragments encompassing this genomic 
region. Abbreviations: R, EcoRi; H, Hindlll; X, Xbal; E, Espl. 
(B) DNAs derived from clonal EScell lines were screen ed byPCR using 
primers P6 and P7. The expected 1.3 kb PCR product was detected in 
lanes corresponding toES clones 4.4 (lane 1), 35.3 (lane 5), and 35,8 
(lane 6), This product was detected in the positive control (lane 9), but 
not in the two negative controls containing mouse genomic DNA (lane 
8) and no DNA (lane 10). 
(C) EcoRI and Hindlll digests of clones 4.4 and 35.3 hybridized with 
a genomic probe (see [A]). In EcoRI digests, two fragments were de- 
tected corresponding to the wild-type (5.4 kb) and mutant (6.4 kb) 
alleles. Similarly, with Hindlll digests, both the wild-type (2.3 kb)and 
mutant (3.3 kb) alleles were detected. As expected, for the non- 
transfected cell line (R1), only the wild-type allele was identified with 
EcoRI and Hindlll digests. 
(D) Agouti offspring of chimeric mice were assessed for germline trans- 
mission by digesting their DNAs with EcoRI, followed by hybridization 
with a genomic probe (see [A]). Thus, wild-type (+/+) and heterozygous 
(+/-) mice were identified. 
Table 1. Generation of Chimeric Mice and Germline 
Transmission of Mutant Allele 
Agouti Germline 
Clone Chimera Agouti (%) Sex Offspring Transmission 
4.4 88 70 M 23 of 32 Yes 
93 50 F -- -- 
97-1 95 M 23 of 23 Yes 
97-2 90 M 24 of 24 Yes 
35.3 94-1 >95 M 23 of 23 Yes 
94-2 >95 M 22 of 22 Yes 
94-3 >95 M 14 of 14 Yes 
94-4 80 F 14 of 14 Yes 
94-5 40 M 0 of 18 No 
100 70 F 0 of 10 No 
35.8 109-1 90 M -- -- 
109-2 80 M 3 of 3 Yes 
109-3 60 M 0 of 21 No 
109-4 10 F -- -- 
Three independently derived correctly targeted ES clones were in- 
jected into blastocyst stage embryos (see Experimental Procedures) 
to generate chimeric animals. The majority of he chimeric animals 
had a very high ES cell contribution as determined by the extent of 
agouti in their coat color. Generally, only males were selected for 
further breeding to identify the germline-transmitting animals. 
lished, and the targeting event was confirmed in each by 
Southern blot analysis. For each cell line, EcoRI and 
Hindlll digests were performed followed by hybridization 
using a 600 bp genomic probe derived from sequences 
outside the region of homologous recombination (Figure 
1A). The predicted sizes for the digested fragments associ- 
ated with the wild-type allele are 5.4 kb and 2.3 kb, respec- 
tively. The insertion in exon 5 results in a corresponding 
increase in fragment lengths from 5.4 kb to 6.4 kb for 
EcoRI and from 2.3 kb to 3.3 kb for Hindlll (see Figure 
1C). In the nontransfected control, R1, only the wild-type 
allele was detected. In the targeted cell lines 4.4, 35.3, 
and 35.8 (data not shown), both wild-type and mutant frag- 
ments were observed at equivalent intensities (Figure 1C). 
Generation of Chimeric Mice 
ES cells from each cell line (4.4, 35.3, and 35.8) carrying 
the targeted Hdh mutation were injected into C57BL/6J 
blastocysts and implanted into pseudopregnant foster 
mothers. Male chimeras were bred to either C57BL/6J or 
chimeric females. All three clones generated high levels 
of chimerism (typically at least 70%), and germline trans- 
mission was achieved for each clone (Table 1). Approxi- 
mately half the agouti pups were heterozygous for the 
mutation (+/-)  and half were wild-type (+/+) (Figure 1D). 
Reverse Transcription-PCR Analysis 
of Heterozygous Mice 
To confirm that the targeted mutation in exon 5 results in 
a null allele, we performed reverse transcription PCR (RT- 
PCR) on RNA from brains of heterozygous mice and a 
wild-type mouse. RNA from two female heterozygous mice 
originating from different ES cell lines (4.4 and 35.3) was 
reverse transcribed using a gene-specific primer (P16) and 
random hexamers. 
The RT product was used as a template for PCR amplifi- 
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Table 2. Genotyping of Liveborn Offspring 
Source 
(Cell Line) (+/+) (+/-) (-/-) 
4.4 46 80 0 
35.3 31 59 0 
35.8 4 5 0 
Total 81 144 0 
Heterozygous mice for each of three ES cell lines (4.4, 35.3, and 35.8) 
were intercrossed, and the resulting liveborn offspring were geno- 
typed. ;~2 = 73.125; df = 2; p < 10 -6. 
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Figure 2. Targeted Disruption Results in a Premature Stop Codon at 
Exon 6 
(A) RT-PCR analysis of heterozygous mice. RNA was extracted from 
two adult heterozygous (+/-) mice derived from EScell lines 4.4 (lanes 
2 and 5) and 35.3 (lanes 3 and 6). As a control, RNA from a wild-type 
mouse (+/+) (lanes 1 and 4) was used. Lanes 7 and 8 are (+/-) centrols. 
The RT-PCR was carried out using a gene-specific primer (lanes 1-3) 
and random hexamers (lanes 4-6). The RT product was amplified 
using primers derived from exons 4 and 6 (see Experimental Proce- 
dures). The expected 248 bp product is seen in all lanes except lane 
8, which has no DNA. However, in lanes 2, 3, 5, and 6, corresponding 
to RT products derived from the heterozygous mice, a short PCR 
product (167 bp) is also seen. 
(B) Sequencing of the shorter (167 bp) RT-PCR product in heterozy- 
gous mice confirms that exon 5 is skipped in the mutant allele. 
(C) In the wild-type allele, all exons are correctly spliced, whereas in 
the mutant allele, exon 5 is skipped, leading to a premature t rmination 
of the translated protein in exon 6. The RNA was reverse transcribed 
with primer P16 and PCR amplified with primers P l l  and P14 (see 
Experimental Procedures). 
cation using primers from exon 3 (P l l )  and exon 6 (P14). 
The expected 248 bp product was generated from RNA of 
both the heterozygous mice and the control mouse (Figu re 
2A). In the heterozygous mice, a shorter product (167 bp) 
was generated as predicted, presumably due to the skip- 
ping of exon 5 (see Figure 2). To confirm this, this product 
was subcloned and sequenced (Figure 2B), revealing that 
the mutation leads to skipping of exon 5 and a frameshift 
resulting in a stop codon immediately downstream of the 
targeting event at nucieotide 673 that results in a severely 
truncated protein of approximately 20 kDa (Figure 2C). 
Western blot analysis of brains from heterozygous mice 
using an antibody (AP78) directed against the N-terminus 
of the protein (Sharp et al., 1995) revealed an approxi- 
mately 340 kDa band indicative of the product from the 
normal allele, and a smaller protein of approximately 20 
kDa that could represent the truncated gene product. 
Disruption of Hdh Mutation Results in Early 
Embryonic Lethality 
Mice heterozygous for the targeted mutation were inter- 
crossed, but no live homozygous Hdh ex5 mice were pro- 
duced among 225 newborns (p < 10 -6) (Table 2) derived 
from all three independently targeted ES cell clones. The 
number of heterozygotes to wild-type mice were present 
in the ratio of approximately 2:1, which allowed us to con- 
clude that the Hdh ex5 homozygotes die in utero. 
To determine the timing of the Hdh eX5 lethality, embryos 
were analyzed at different stages during gestation. From 
embryonic day 7.5 (E7.5) to E12.5, 173 decidua analyzed 
contained morphologically normal embryos (Table 3), 
Whereas the remaining 51 contained nearly or completely 
resorbed embryos, 35 of which were recovered for geno- 
typing (Table 4). The embryos were genotyped by South- 
ern blot or PCR analysis (Figures 3A and 3B). Normal 
embryos were in the expected ratios for genotypes (+/+) 
or (+/-), but only four (2O/o) phenotypically normal embryos 
(two at E7.5) had the ( - / - )  genotype (Table 3). The majority 
(800/0) of resorbed embryos were homozygous for the 
Hdh ~x5 mutation (Table 4). These data indicate that loss of 
function of the endogenous Hdh gene results in embryonic 
lethality during early postimplantation development. 
Histological Analysis of Embryos 
From E7.5 to E9,5, a high frequency of resorption in the 
litters of heterozygote crosses was observed (40 of 187 
or 21.3%). At E8.5, the ratio of ( - / - )  versus (+/+) or (+/-) 
resorbed embryos increased, indicating that more Hdh ex5 
homozygotes were dying. 
Sections from 67 embryos produced by heterozygous 
intercrosses were examined. Litters ranged in age from 
7 to 8.5 days gestation, during which time the major events 
of gastrulation have occurred: elongation of the primitive 
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Table 3. Genotyping of Phenotypically Normal Embryos 
at Different Stages of Gestation 
Day of 
Gestation (+/+) (+/-) (-/-) 
7.5 23 24 2 
8.5 16 46 2 
9.5 9 16 0 
10.5 8 12 0 
11.5 2 6 0 
12.5 1 6 0 
Total 59 110 4 
Timed matings were set up between heterozygous animals for each 
clone, and both normal and resorbed embryos were collected at differ- 
ent stages of gestation (E7.5-E12.5). X2 = 47.5818; df = 2; p < 10 -6.
A 
240 - 
210 - 
I - -  ElO.5 - - I I - -  ES.5 I 
+/- +/+ +/+ +/+ +/+ -l- +/- +/- +/- 
streak, formation of mesoderm, formation of headfolds, 
and the formation of somites and branchial arches. The 
abnormal embryos (19 of 67 or 28.36%) could be distin- 
guished by their immaturity compared with normal lit- 
terrnates (compare Figure 4A with Figure 4B; compare 
Figure 4C with Figure 4D). The disparity in development 
was most evident in the older litters, collected at 7.75 and 
8.5 days gestation. 
The normal embryos exhibited well-developed head- 
folds and epithelial-stage somites (Figures 4F and 4H; data 
not shown), whereas the abnormal l ittermates only 
reached late primitive streak stage (Figures 4G and 41). 
In the developmental ly delayed embryos, there was no 
indication that a neural plate had formed (compare Figures 
4C and 4D), although mesoderm had accumulated be- 
tween the ectoderm and endoderm. The extraembryonic 
membranes were present in the abnormal embryos in the 
same arrangement as in normal embryos (Figure 4E; data 
not shown). However, the size of the membranes was re- 
duced, and a connection between the allantois and the 
placenta was not achieved. The phenotype of abnormal 
embryos closely matches that of the dissected, genotyped 
embryos (compare Figures 4B and 4D with Figures 41 and 
4J). Null mutants deteriorated rapidly after 8.5 days, and 
little structure remained by 10.5 days gestation (Figure 4K). 
Behavioral Assessment 
Seven mice heterozygous for the Hdh ex5 mutation and 
seven wild-type mice (+/+) from related litters were as- 
Table 4. Genotyping of Resorbed Embryos at Different 
Stages of Gestation 
Day of 
Gestation (+1+) (+1-) ( - I - )  
7.5 2 1 2 
8.5 1 1 12 
9.5 -- 1 9 
10.5 1 -- 2 
11.5 -- -- 2 
12.5 - -- 1 
Total 4 3 28 
Timed matings were set up between heterozygous animals for each 
clone, and both normal and resorbed embryos werecollected at differ- 
ent stages of gestation (E7.5-E12.5). X2 = 70.7321; df = 2; p < 10 -6.
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Figure 3. Genotype Analysis of Embryos at Different Stages of Ges- 
tation 
(A) Embryos were incubated overnight in a lysis buffer including pro- 
teinase K and were analyzed by PCR with primers P8, Pg, and P586 
(see Experimental Procedures). The PCR products were run on 2% 
agarose gels to resolve the wild-type (210 bp) and mutant (240 bp) 
alleles. 
(B) For Southern blot analysis, DNA was isolated as described else- 
where (Hogan et al., 1986). The DNA was digested with EcoRI, blotted, 
and hybridized with a genomic probe (Figure 1A). The wild-type and 
mutant alleles are associated with fragment sizes of 5.4 kb and 6.4 
kb, respectively. 
sessed. All mice were 4-month-old males. Mutant mice ate 
and drank normally, were indistinguishable from controls 
with respect to body weight, posture, locomotion, rearing, 
and grooming, and did not display any signs of ataxia. 
Mutant mice were distinctly more reactive to handling. For 
all tests, the experimenter was blind to the genetic status 
of the animals. 
Motor Activity Test 
This test assessed spontaneous motor activity in a hori- 
zontal plane, as measured by overall level of activity and 
the habituation to a novel stimulus during each separate 
2 hr phase of the test. The mutant mice were significantly 
more active than controls (p < 0.01) throughout both 
phases, with no overlap between the groups (in the light- 
phase mutant, 2162 __. 163; control, 1557 _+ 163; p < 
0.05; in the dark-phase mutant, 1383 _ 133; control, 714 
± 133; p < 0.005) (Figure 5A). Activity scores of both 
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Figure 4. Mouse Embryos Produced by Het- 
erozygous Intercrosses 
Embryos in (A), (B), (H), (I), and (K) were geno- 
typed using PCR. The scale bar for whole em-
bryos is 500 ~.m; the scale bar for sectioned 
embryos is 250 pro. Abbreviations: A, allantois; 
E, embryonic ectoderm; EPC, ectoplacental 
cone; EN, embryonic endoderm; HF, headfold; 
H, heart; M, mesoderm; NG, neural groove; 
RE, resorbing embryo; S, somite. 
(A) Heterozygous embryo dissected out of the 
decidua. Headfolds have begun to form at the 
anterior end of the embryo. 
(B) Homozygous littermate of the embryo in (A). 
The embryo is very small and underdeveloped. 
(C) Transverse section of an E7.5 normal em-
bryo. The neural groove has begun to form in 
this early neurula-stage embryo. 
(D) Transverse section of an abnormal (E7.5) 
embryo. Mesoderm has formed around the em- 
bryonic ectoderm. The size of the embryo is 
considerably smaller than the normal embryo 
shown in (C). 
(E) Parasagittal section of an abnormal (E7.5) 
embryo shows that a small amount of meso- 
derm has formed inthe embryo. However, ex- 
traembryonic membranes are fragmented, and 
the process of resorption may be beginning. 
(F) Transverse section through the headfold re- 
gion of an E7.75 normal embryo. 
(G) Transverse section through an abnormal 
(E7.75) embryo shows that mesoderm has 
formed. However, the ectoderm is not thick- 
ened, as occurs normally at the onset of neuru- 
lation. 
(H) Heterozygous embryo (E8.5) dissected out 
of decidua. Prominent headfolds, heart, and 
somites are visible. 
(I) Homozygous littermate to the embryo in (H). 
The size of the embryo is considerably smaller 
than its normal littermate. 
(J) Transverse section of an abnormal E8.5 em- 
bryo in which development is similar to that of 
the embryo in (I). The embryo is very small and 
looks similar to abnormal embryos observed at 
7.5 and 7.75 days gestation. Mesoderm has 
formed, but neurulation has not begun. 
(K) Section through an E10.5 (-/-) resorbing 
embryo showing complete disorganization of 
embryonic tissue layers and membranes. I - 
set shows appearance of small undeveloped 
embryo and membranes prior to sectioning. 
groups declined significantly across successive 10 min 
time bins (p < 0.01). 
T Maze Alternation Test 
This test allows general assessment of simple discrimina- 
tion learning and short-term memory. Both groups learned 
this task at the same rate (F[2,20] = 12.349; p < 0.001) 
and reached asymptotic performance of 80% or greater 
correct responses by training day 3. They also did not 
differ in mean latency to reach the food cup after release 
(Hdh ex5 mice, 35.6 _.+ 2.9 s; control mice, 39.1 _+ 7.1 s), 
which provides confirmation that mutant mice did not have 
impairments in locomotion and that motivation was nor- 
mal. One animal in both the mutant and control groups 
did not eat Froot Loops during any trial on the T maze, 
and therefore their data were not analyzed. 
Radial.Arm Maze Test 
This provides a direct test of working memory. Control 
animals quickly learn not to revisit arms explored pre- 
viously within a trial and thus acquire the four pieces of 
food with minimum effort. Data were excluded from the 
Cell 
816 
A 
350" 
300-  
250-  
0 200" 
8 o 150" "5 
lO0- 
50" 
B® 
C 
z0o0 
I Light phase Total 
6 ~ 12 1'5 1'8 2'1 2~4 
Light Phase I 
lO Min Bins 
O,==, 
100 
~"  75 75 **  
¢:: 50 \ 50 
25 ~ 25 
00 1 2 3 4 5 6 7 8 00 1 2 3 4 5 
Blocks of 2 Trials Blocks of 2 Trials 
Memory Probe I Memory Probe 2 
" ' : rL ,L ,L .m . . . .  ': . . . . . .  
D Memory Probe I Memory Probe 2 
'f 
~34 
i: 
Mutant control 
Figure 5. Behavioral Studies in Mice Heterozygous for the Hdh ~x5 Mu- 
tation 
(A) Locomotion activity (mean _+ SE M) as measured by photocell beam 
breaks for Hc/h ~5 knockout mice (closed squares) and controls (open 
circles) during the light and dark phases of the 4 hr testing session. 
Hdh ~'5 mice were more active relative to controls over the entire session 
(F[1,12] = 10.687; p< 0.01). Mice in both conditions showed habitua- 
tion over the session (F[11,132] = 5.305; p < 0.001). There was no 
significant interaction. Insert graphs show total photocell counts (mean 
_+ SEM) for Hdh .x5 mice (closed bar) and control mice (hatched bar) 
for the light phase and dark phase of the locomotion testing session. 
Hdh ex5 mice were more active during both the light phase (F[1,12] = 
6.841; p < 0.05) and dark phase (F[1,12] = 12.509; p < 0.005) than 
control mice (*, p < 0.05; **, p < 0.01). 
(B) Morris water maze testing. Latencies to find the hidden platform 
(mean +_ SEM) for Hdh ~5 mice (closed squares) and controls (open 
circles) with the platform in the original position (left) and during the 
reversal (right) when the platform was moved to the opposite quadrant. 
A highly significant effect of trial was observed (F[12,144] = 9.639; 
p < 0.001), indicating that both groups of mice showed improvements 
in performance over trials. Furthermore, a significant interaction was 
observed (F[12,144] = 2.366; p < 0.01 )~ Hdh "~ mice were significantly 
slower to find the hidden platform during blocks 1, 3, 4, and 5 of the 
reversal trial (*, p < 0.05; **, p < 0.01). 
(C) Percentage of time spent in the four quadrants of the water maze 
during memory probe trial 1 (left) and trial 2 (right), given after the 
initial acquisition and reversal phases, respectively. Analysis of the 
memory trial showed that mice in both groups spent more time in 
same two mice that once again did not eat during this test. 
Although the performance of the mutant mice, as measured 
by reentry errors, was highly variable, the mutant group did 
not differ from controls, and both groups made fewer errors 
as the experiment proceeded (F[16,60] = 2.757; p < 0.05). 
Hdh ex5 mice made 2.0 _ 0.05 revisit errors on training day 
7 compared with 1.0 _+ 0.47 errors by the control group. 
Morris Water Maze Task 
The Morris water maze task (Morris, 1981) has been used 
routinely to study the ability of rodents to acquire spatial 
information. Measures of path length and latency to reach 
a submerged platform were grouped across acquisition 
and reversal phases. Both groups of mice showed im- 
provement over 1 6 trials. An alyses of the latency data con- 
firmed that Hdl ' f  x5 mice had acquired the necessary spatial 
information to locate the hidden platform efficiently (see 
Figure 5B). A separate analysis of the path length mea- 
surements showed no effect of genotype and a significant 
effect of trial (F[12,144] = 17.31 ; p -- 0.001) with no signifi- 
cant interaction. Two mutant mice remained motionless 
for 20-30 s periods during several of the reversal trials, 
which may have enhanced the latency scores without in- 
creasing path length. 
Data from the memory probe trial demonstrated appro- 
priate memory for the location of the platform site by both 
Hdh ~x5 and control mice, reflected by the greater percent- 
age of time spent by both groups in the northwest quadrant 
of the pool (p < 0.001) (see Figure 5C), where the platform 
had previously been located. Both Hdh ~x5 and control mice 
made a comparable number of crosses over the platform 
site (Figure 5D). 
Deficits were, however, observed when mutants were 
required to reverse their spatial response by swimming to 
the hidden platform in a new location (Figure 5B). Latency 
data from the Hdh ex5 group were significantly greater than 
in the control group on the first, third, fourth, and fifth 
blocks of trials (p < 0.01). A second memory probe trial 
conducted immediately after the tenth reversal trial con- 
firmed the impairment (Figure 5C). Control mice again 
spent a significantly greater percentage of the trial swim- 
ming in the quadrant in which the platform had been relo- 
cated (p < 0.01). By contrast, Hdh ex5 mice distributed their 
swimming time equally across all four quadrants. This dif- 
ference was highlighted by the finding that control mice 
crossed the new platform site in the southeast quadrant 
the quadrant where the platform had recently been locate d (stippled 
bar) relativetotheotherthreequadrants(open bars)(F[3,36] = 14,695; 
p < 0.001 ; Tukey's post hoc, p < 0.01). During memory probe trial 2, 
a significant interaction was observed (F[3,36] = 8.194; p < 0.01), 
Control mice spent more time in the quadrant where the platform had 
recently been located (stippled bar) relative to the other three quad- 
rants (open bars) (p < 0.01), while Hdh ex5 mice distributed their swim 
time equally across all four quadrants (*, p < 0.05). 
(D) Number of crosses of the location of the platform (mean _. SEM) 
for Hdh ~x5 knockout mice (closed bar) and controls (hatched bar) during 
memory probe trial 1 (left) and memory probe trial 2 (right). No differ- 
ences between groups were observed during memory probe trial 1. 
However, control mice crossed the location of the platform significantly 
more often tban Hdh ~'5 mice during memory probe trial 2 following 
reversal training (F[1,12] = 5.408; p < 0.05). Asterisk denotes signifi- 
cance at p < 0.05. 
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Figure 6. Nissl Sections through the Subthalamic Nucleus 
The subthalamic nucleus was easily recognized in both wild-type con- 
trols (A) and heterozygous mice (B) as a small elongated nucleus con- 
taining densely packed, darkly stained neurons located between the 
zone incerta dorsally and the cerebral peduncle ventrally. The nucleus 
is ovoid medially (left) with a tail extending laterally (right). Note the 
decreased size of the nucleus in (B), which is most evident in the 
middle third. Scale bar, 300 I~m. 
more than twice as frequently as did the mutant mice 
(p <0.05). Normal acquisition and memory of spatial infor- 
mation coupled with the marked impairment seen in the 
reversal trials suggest that Hdh ex5 mice have cognitive defi- 
cits associated with acquiring or using new information in 
the face of existing information. 
Histology and Morphometry of Brains 
of Heterozygotes 
Two heterozygous mice with the most severe performance 
deficits were sacrificed for neuropathological examina- 
tion. The morphology of the central nervous system in the 
heterozygous mice appeared relatively normal, with no 
signs of gross malformations or obvious developmental 
abnormalities. Examining the serial Nissl sections re- 
vealed no signs of neuronal necrosis, gliosis, or inflamma- 
tion. In the heterozygous mice, there appeared to be a 
decrease in the size of the subthalamic nucleus (Figure 
6). There were no obvious differences in the morphology 
of the caudate/putamen (Figure 7), although there ap- 
peared to be a decrease in the number of neurons in the 
globus pallidus (see Table 5). The cerebral cortex and 
corpus callosum appeared normal. 
Figure 7. Nissl Sections through the Striatum 
Frontal sections through the caudate/putamen (cp) and globus pallidus 
(gp) of wild-type control (A)and heterozygous mice (B) are shown. 
Scale bar, 500 p_m. 
There were no differences in mean brain weight, in the 
volumes of the caudate/putamen, globus pallidus, sub- 
stantia nigra, and hippocampus, and in the thickness of 
motor cortex (see Table 5). However, the volume of the 
subthalamic nucleus was found to be significantly reduced 
in heterozygous mice (t -- 7.256; df -- 2; P = 0.018). The 
numerical density of neurons (Nv) did not differ signifi- 
cantly in any of the regions examined. When the total num- 
ber of neurons in a region was calculated from estimates of 
neuronal Nv and regional volume, there were significantly 
fewer neurons (approximately 45°'0) in the subthalamic 
nucleus of heterozygous mice (t = 6.849; df -- 2; P -- 
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Table 5. Morphometric Variables of Brains of Heterozygotes for the Hdh ex5 Mutation and Controls 
Measurement Control (n = 2) Heterozygotes (n = 2) P Value 
Brain weight (mg) 400 __ 10 430 __. 10 NS 
Caudate/putamen 
Volume (mm 3) 9.849 ± 0.333 8.988 ± 1.188 NS 
Nv neurons 128,748 ± 11,703 140,555 ± 21,347 NS 
Total neurons 1,217,788 ± 68,172 1,237,954 ± 24,882 NS 
Neuron profiles (p.m 2) 108 ± 1 100 ± 13 NS 
Globus pallidus 
Volume (mm 2) 1.075152 ± 0.019443 0.817519 ± 0.127867 NS 
Nv neurons 34,831 ± 2,845 26,994 ± 4,986 NS 
Total neurons 37,504 ± 3,736 21,430 ± 625 NS 
Neuron profiles (p_m 2) 225 ± 1 178 ± 13 NS 
Subthalamic nucleus 
Volume (mm 3) 0.132678 _ 0.005970 0.089158 ± 0.000573 0.01 
Nv neurons 201,313 _ 2,532 170,719 __. 13,906 NS 
Total neurons 26,725 ± 1,538 14,729 ± 838 0.02 
Neuron profiles (l.[m 2) 118 ± 4 114 + 19 NS 
Substantia nigra 
Volume (mm3), pars compacta 0.156043 ± 0.004276 0.136227 ± 0.015522 NS 
Volume (mm~), pars reticulata 0.414868 ± 0.030772 0.351587 ± 0.062205 NS 
Nv neurons, pars reticulata 21,925 ± 2,635 21,272 ± 707 NS 
Total neurons, pars reticulata 9,015 ± 419 7,435 ± 1,075 NS 
Neuron profiles (p.m 2) 209 ± 12 195 ± 11 NS 
Hippocampus 
Volume (m@) 9.459 ± 0.489 10.005 ± 0.957 NS 
Motor Cortex 
Thickness (p.m 2) 1088 ± 51 1083 ± 118 NS 
Values are given as means ± SEMs. NS, not significant. 
0.021). In the globus pallidus, the mean value for total 
neuron number was 43% less in heterozygous mice com- 
pared with controls, but this difference was only of border- 
line significance (t -- 4.243; df -- 2; P = 0.051). The mean 
neuronal profile area was similar between the two groups 
in all the regions examined. 
Discussion 
Targeted Disruption of the Hdh Gene Results in 
Early Embryolethality 
To explore the normal function of the HD gene and its role 
in development, we have disrupted the murine Hdh gene 
in exon 5 (Hdhexs). NO liveborn mice (0 of 225) homozygous 
for Hdh ex5 were evident (Table 2; p < 10-6). Because the 
liveborn progeny were derived from intercrosses of hetero- 
zygotes originating from three independently targeted ES 
cell lines, the lack of Hdh ~x5 live offspring is not due to 
another mutation inadvertently generated in one ES cell 
line. These data clearly show that homozygosity for the 
Hdh ~x5 mutation is lethal during embryonic development. 
Analysis of 1 73 phenotypically normal embryos at differ- 
ent stages of gestation revealed that only four (2.37%) 
were homozygous mutants (Table 3; p < 10-8). In contrast, 
genotyping of 35 resorbed embryos from 7.5 to 12.5 days 
gestation revealed that 28 (80%) were homozygous mu- 
tants (Table 4; p < 10-6). The high frequency of postimplan- 
tation resorptions, lack of phenotypically normal-looking 
Hdh mutant ( - / - )  embryos after 8.5 days of gestation, 
and complete absence of liveborns homozygous for this 
mutation clearly show that the murine Hdh gene is essen- 
tial for early postimplantation development. 
Hdh ~5 mutants die at around E7.5 and display a pheno- 
type in which gastrulation is significantly disturbed (Figure 
4). During gastrulation in mammalian development, the 
three germ layers (ectoderm, mesoderm, and endoderm) 
are generated. While the precise cause of embryolethality 
is not yet determined, our results suggest that although 
the three germ layers are formed, subsequent failure to 
neurulate leads to complete disorganization of the embryo 
such that it never forms somites, nodes, or the notochord 
and does not proceed to organogenesis. 
This indicates that mesoderm is formed, but that the 
normal Hdh protein may be critical for neurulation and 
development of the anterior-posterior axis. It is possible 
that inductive events between the chordamesoderm and 
surface ectoderm do not occur in the homozygous mutant 
embryos, leading to cessation of development. Clearly, 
the HD gene plays a crucial role in normal gastrulation. 
Numerous other naturally occurring mutations and gene 
targeting experiments have also been shown to result in 
lethality during gastrulation due to primary disturbances 
in the primitive ctoderm (reviewed by Copp, 1995). These 
studies suggest that many of these genes, including the 
HD gene, may play crucial roles either as regulatory mole- 
cules underlying astrulation in vertebrates or for essential 
cellular housekeeping functions that may be important for 
exchanging nutrients with the mother (Copp, 1995). 
Behavioral Changes in Heterozygous Mice 
with the Hdh ex5 Mutation 
Hdh ex5 mice differed from controls in several important 
ways, the most apparent being increased reactivity to han- 
dling. These mice were more active than controls when 
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placed in a novel photocell cage. This effect was seen in 
both light and dark conditions, in which crossings were 
more than two times greater in the heterozygous mice. 
Taken together, the motor activity data suggest that the 
Hdh ~5 mice habituate more slowly to the stimulus features 
of a novel environment and therefore remain more active 
than controls during both phases of the motor activity test. 
These changes in motor activity appear to be quite spe- 
cific, as the Hdl ' t  x5 mice performed normally on two spatial 
tasks (Figure 5). 
T maze alternation, the 8-arm maze, and foraging for 
food assess the ability of a rodent to use memory of previ- 
ous responses within a trial to plan subsequent responses 
and spatial function. Both groups of mice performed these 
maze tasks equally well, indicating normal short-term 
memory and spatial function. 
The performance of Hdh ~x5 mice on the Morris water 
maze task was particularly revealing. The hidden platform 
version of this task has been used to provide an unambigu- 
ous assessment of spatial abilities in rodents (Morris, 
1981). When tested for the first time with the hidden plat- 
form in a fixed location, mutant mice performed as well as 
controls, with both groups showing normal learning curves 
and intact spatial memory on a memory probe trial (Figure 
5). Therefore, it seems that Hdh ex5 mice have normal ca- 
pacity for spatial navigation, memory for location in space, 
and normal short-term learning ability. Furthermore, they 
must have the normal perceptual and motor capacities 
required to see extramaze visual stimuli located in the test 
room and to exhibit normal swimming behavior. 
Despite normal functioning on the preceding phase of 
spatial learning in the water maze, mutant mice were se- 
verely affected during the reversal trials (Figure 5). They 
failed to reach the same degree of proficiency in latency 
to reach the platform and showed no memo ry of the correct 
platform location during a memory probe trial in which the 
platform was removed from the pool. This may reflect a 
deficit in cognitive flexibility in which a previously success- 
ful strategy must be inhibited to develop a new strategy 
that is appropriate for a change in the demands of the 
task. Mutant mice appeared to be incapable of making 
this strategy switch. It is noteworthy that behavioral differ- 
ences seen in Hdh ~`5 mice relative to controls are similar 
to those seen in rodents with lesions to the basal ganglia. 
Deficits in switching from one set of learned responses 
to another is a well-documented behavioral correlate of 
damage to the basal ganglia and, in particular, to the dor- 
sal striatum (Robbins and Everitt, 1992). Proactive interfer- 
ence by the original memory of the location of the platform 
may provide an alternative xplanation of these data. Kai- 
nic acid lesions of the dorsal striatum that in part reproduce 
the neurochemical profile of HD can also cause an in- 
crease in spontaneous locomotor activity (Dunnet and 
Iverson, 1981). Rats with similar lesions performed nor- 
mally in the initial acquisition of a water maze task, but 
when the platform was moved to another quadrant, le- 
sioned animals were impaired relative to controls (McDon- 
ald and White, 1994)i findings similar to those seen in 
Hdh ~x5 mice. 
Morphological Changes in the Brains of Mice 
Heterozygous for the Hdh "xs Mutation 
We have demonstrated significant decreases in both the 
volume of the subthalamic nucleus and the total number 
of subthalamic neurons in the two heterozygous mice com- 
pared with two littermate controls (Figure 6; Table 5). The 
total number of neurons in the globus pallidus appeared 
to be reduced, although morphometric analyses would be 
required on a larger subject sample to verify this observa- 
tion. In contrast, no differences at all were seen in the 
caudate/putamen, substantia nigra, and hippocampus or 
in the thickness of the cerebral cortex. The 45% reduction 
in the number of subthalamic neurons in heterozygous 
mice could result from decreased neurogenesis during 
prenatal development or from increased apoptosis during 
late prenatal or early postnatal development. A third possi- 
bility is that subthalamic neuron loss is due to necrosis 
during early development, with rapid dissolution of ne- 
crotic tissue and no residual gliosis at 4 months of age. 
Alternatively, the influence of two genetic backgrounds on 
the growth of the subthalamic nucleus between heterozy- 
gotes and littermates has not been excluded. 
The subthalamic nucleus, which is one of the five nuclei 
comprising the basal ganglia, functions in the extrapyrami- 
dal control of movement and has previously been impli- 
cated in the pathophysiology of HD (Folstein, 1989; 
Harper, 1991; Parent and Hazrati, 1995). Although neu- 
ronal loss from the subthalamic nucleus has been reported 
in HD (Lange et al., 1976), characteristic lesions involve 
a substantial oss of GABAergic medium-spiny neurons 
in the neostriatum (Lange et al., 1976; Graveland et al., 
1985). In the early years of symptomatic HD, pathology 
in the neostriatum is minimal (Vonsattel et al., 1985), indi- 
cating that the pathophysiology of chorea precedes obvi- 
ous necrosis in the basal ganglia. One question that arises 
is whether changes in the subthalamic nucleus might in 
some way be related to the Striatal pathology and clinical 
phenotype of HD. It has previously been suggested that 
striatal lesions in HD alter the physiology of subthalamic 
neurons to produce chorea (Albin et al., 1989). Interest- 
ingly, acute lesions of the subthalamic nucleus due to 
stroke (Whittier, 1947) or induced experimentally in pri- 
mates (Carpenter et al., 1950) manifest, with ballismus 
that is exaggerated, high amplitude chorea. In contrast, 
little is known concerning the effect of chronic, continued 
damage to the subthalamic nucleus. 
Implications for the Pathogenesis of HD 
The Hdh ex5 mutation in the murine HD gene results in em- 
bryolethality before E8.5, indicating that this gene is ex- 
pressed very early in development and that there is no 
functional redundancy for this gene. In contrast, humans 
homozygous for the CAG mutation survive and have a 
phenotype (Wexler et al., 1987; Myers et al., 1989; Kremer 
et al., 1994) similar to heterozygotes for this mutation. 
Furthermore, there is no report of increased miscarriage 
rate in offspring of parents both heterozygous for the HD 
mutation. Taken together, these data provide compelling 
evidence that CAG expansion in the HD gene does not 
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result in complete loss of normal function of this gene. 
Furthermore, our data showing lethality of the mutant al- 
lele also argue against a complete dominant negative 
mechanism for the pathogenesis of HD in which the mu- 
tant gene results in complete loss of its own function and 
also inactivates the normal product. In contrast, the find- 
ings of embryolethality for mice homozygous for the muta- 
tion and equivalence of the homozygote and heterozygote 
phenotype of HD in humans are more compatible with 
CAG expansion, conferring a novel gain of function inde- 
pendent of the normal physiological role of the protein. 
Recent evidence clearly shows that the CAG repeat in the 
HD gene is indeed translated into a polyglutamine stretch 
(Jou and Myers, 1995; Sharp et al., 1995). 
Mice heterozygous for the Hdh ex5 mutation have behav- 
ioral deficits similar to that seen in rodents with lesions in 
the striatum, and two of these same mice analyzed have 
significant reductions of neurons in the subthalamic nu- 
cleus. Intriguingly, this nucleus also shows obvious neu- 
ronal loss (25%) in patients with HD (Lange et al., 1976), 
which raises the question whether partial loss of normal 
function of this gene could result in neuronal loss in the 
basal ganglia. An alternative possibility is that expression 
of the truncated HD protein in the heterozygous mice re- 
sults in a phenotype with some similarity to HD not due 
to partial oss of function, but due to the truncated protein 
acting as a toxic product. 
Interestingly, CAG expansion in the androgen receptor 
gene is associated with X-linked spinal and bulbar muscu- 
lar atrophy (La Spada et al., 1991), but affected males also 
have signs of partial toss of normal androgen receptor 
function, manifested with gynecomastia nd reduced fer- 
tility (Arbizu et al., 1983). While CAG amplification in the 
androgen receptor gene confers novel functional proper- 
ties (Mahtre et al., 1993), this is associated at the same 
time with partial loss of normal function. Pathological 
involvement of the basal ganglia in mice heterozygous for 
the Hdh ex5 mutation suggests that partial loss of normal 
function of the HD gene might also contribute to the pheno- 
type of HD. 
Data presented here suggest that the HD gene plays 
an essential function during gastrulation in early em- 
bryogenesis and that it may also have an important physio- 
logical role in the basal ganglia. Similar to the androgen 
receptor gene, it is possible that CAG expansion in the HD 
gene also results in partial oss of physiological function of 
this gene, with subsequent mild deficits in this region of 
the brain. Partial loss of normal function, however, would 
be insufficient o result in a clinical phenotype. For exam- 
ple, one patient with a balanced translocation that dis- 
rupted the HD gene between exons 41 and 42 was still 
asymptomatic at age 46. In this patient, however, the pro- 
tein contains nearly two thirds of the normal product, which 
may be sufficient o exert its normal physiological role (Am- 
brose et al., 1994). 
We therefore propose a model for the pathogenesis of 
HD that involves a gain of novel properties, in addition to 
a partial loss of its normal physiological role. Selective 
neuronal death caused by dysfunction of this widely ex- 
pressed gene could reflect restricted expression of a pro- 
tein that has altered interaction with an HD gene product 
with an expanded polyglutamine stretch. In addition, par- 
tial loss of the physiological role of this gene in the basal 
ganglia could also contribute to the HD phenotype. 
This model could have important implications for the 
design of therapeutic strategies as well as novel research 
directions. One approach to treatment of H D is to decrease 
the expression of the HD gene, and this might be expected 
to mitigate the phenotype. An alternate approach may be 
to determine which cellular proteins specifically interact 
with the HD gene product and to direct attention to interfer- 
ence with this interaction. This approach could also be 
insufficient o cure HD, as additional strategies to replace 
the partial loss of normal function of the HD gene may be 
necessary to reach that goal. 
Experimental Procedures 
Constructing the pHdhNeo6 Targeting Vector 
A phage genomic library from the 129/Sv mouse strain (Stratagene) 
was screened using a probe encompassing exon 5 of the murine Hdh 
cDNA (Lin et al., 1994). A 5.4 kb genomic fragment including murine 
exons 4 and 5 was subcloned into pBluescriptll KS(+) (Stratagene). 
A 3.5 kb EcoRI-Xbal clone was derived by digestion with Espl to re- 
move a 600 bp fragment encompassing intron 4 and approximately 
half of exon 5 (see Figure 1A). The Espl site was end-filled with Klenow 
(Sambrook et al., 1989), and a blunt-ended EcoRI-Xhol fragment from 
PGKneobpA (Soriano et al., 1991) was introduced. 
Detecting Homologous Recombination in ES Cells 
PCR was used to screen for homologous recombination using primers 
P6 (GGAGGCTAGAATGCTTGCAG) and P7 (TCTATGGCTTCTGAG- 
GCGGA). Following an initial denaturation step (96°C for 1 min), 40 
cycles of PCR were performed (94°C for 1 min, 60°C for 90 s, 72°C 
for 120 s) with a final step of 72°C for 10 rain, using the 9600 Perkin- 
Elmer machine. 
Generation of Germline Chimeras 
Blastocysts were collected from pregnant C57BU6J females at 3.5 
days postcoitum. Approximately 8-10 ES cells were microinjected and 
implanted into pseudopregnant ICR foster mothers. Chimeras identi- 
fied by the presence of an agouti coat color were test-mated with 
C57BU6J females. Agouti offspring were tested for the targeted Hdh 
gene by Southern blotting. 
RT-PCR and Sequencing 
Total mRNA was extracted from freshly isolated tissue using the gua- 
nidium isothiocynanate method (Chomczynski and Sacchi, 1987). 
Poly(A) ÷ RNA was extracted using the Micro-Fast Track mRNA isola- 
tion kit (Invitrogen Corporation). RT was performed using the Super- 
Script preamplification system (GIBCO BRL) with both a gene-specifie 
primer (P16) (AATTTCATTGTCATTTGCGA) and random hexamers in 
separate reactions. The RT product (5 p.I) was used for PCR ampiifica- 
tion using primers P11 (CGATGCGGAGTCAGATGTCA) and P14 (GGT- 
CII I  IGCI-rG'I-rCGGGT). The shorter 167 bp PCR product was 
subcloned using the TA cloning kit (Invitrogen Corporation) and se- 
quenced using an Applied Biosystems automated sequencer. 
Genotype Analysis 
For PCR analysis, embryos were incubated overnight in a iysis buffer 
containing 20 mM Tris, 50 mM KCI, 0.45% NP-40, 0.45% Tween-20, 
0.01% gelatin, and 100 p.g/ml proteinase K and overlaid with mineral 
oil. The samples were then incubated at 94°C for 10 min, and 5 ~1 
was used for a 25 p~l PCR in the 9600 Perkin-Elmer machine. Genotyp- 
ing was carried out using P8 (TGGCAAGACAATAGCAGGCA), a neo- 
specific primer; P586 (AGTI-rGCGTGCTGCCCTGTG), a primer de- 
rived from exon 5 of mouse; and P9 (CCAGACAGGACATAGCTAGG), 
a primer from intron 5 (Figure 1). All three primers (PS, P9, and P586) 
were used together in a single PCR. 
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Histology 
Embryos and whole decidua were fixed in Bouin's solution and embed- 
ded in paraffin wax. Serial sections of 5 p.m were prepared and stained 
with hematoxylin and eosin. 
Behavior Studies 
Locomotion Test 
Spontaneous locomotion was assessed using three clear Plexiglas 
photocell cages (25 cmx 25 cm x 26 cm) placed individually inside 
large dark chambers (45 cm x 45 cmx 100 cm). Individual photocell 
cages were illuminated by a 70 mW light bulb and had four parallel 
infrared photocell beams (two on each axis) located 2 cm above the 
floor and 8 cm from each corner of the cage. Interruptions of any beam 
were registered incrementally by a microcomputer and were summed 
in 10 rain bins during the locomotion test. Mice were placed individually 
in the apparatus, and spontaneous locomotion was assessed for a 4 
hr trial. For the first 2 hr, the house lights were left on (light phase), 
and for the final 2 hr the lights were off (dark phase). Mice were tested 
in the middle of their light cycles, between 1 p.m. and 5 p.m. 
T Maze Alternation Test 
Following the locomotion test, mice were housed individually and were 
deprived of food over 7 days to 85%-90% of their free-feeding weight. 
Mice were then tested for reinforced alternation responses on a T 
maze. The T maze was made of clear Plexiglass and consisted of a 
two goal arms (20 cmx 10 cm x 12 cm), each with a small plastic 
food cup (3 cm diameter and 0.5 cm deep) at the distal end, and a 
start arm (36 cmx 10 cmx 12 cm), which could be blocked off by 
a wooden barrier (10 cmx 18 cm). On the first 2 days, each animal 
was habituated to the T maze for a 10 rain period, during which pieces 
of Kellogg's Froot Loops cereal were distributed on the T maze. Ani- 
mals were subsequently tested on a standard alternation paradigm 
for 3 days. The first trial was a forced choice in which mice could enter 
only one baited goal arm, chosen at random. After entering the open 
arm, the mouse was confined there until food was consumed, following 
which the mouse was placed back in the start arm and confined for 
15 s. In 12 subsequent rials per day, we required the animals to choose 
the opposite arm from the one visited on the previous trial to receive 
food reinforcement. Following a correct choice, the mouse was again 
confined to the goal arm until it had eaten the food. An incorrect choice 
resulted in confinement in that arm for 30 s, after which the mouse 
was placed in the start arm to await the next trial. The number of 
correct choices and the latency to reach the food cup of the chosen 
arm were recorded. 
Radial.Arm Maze Test 
At 1 week after the completion of the T maze alternation tests, mice 
were given 7 days of testing on a radial-arm maze task. The maze 
was constructed from plywood and consisted of a central octagonal 
platform (35 cm diameter) with eight arms radiating from the platform 
(35 cmx 9 cm) with a plastic food cup at the distal end of each arm. 
On day 1 of training, food was distributed around the center of the 
platform and in the food cups of four randomly selected arms. Individ- 
ual mice were placed in the center of the maze and permitted to forage 
until all four pieces of food had been eaten from the food cups and 
all eight arms had been visited or until 10 min had elapsed. For all 
subsequent daily trials, pellets were placed in the food cups of four 
arms selected at random. A novel set of four arms was chosen each 
day, and optimal foraging behavior equired animals to minimize reen- 
tries into arms visited previously within a daily trial. Errors were scored 
as revisits to any arm entered previously. The experimenter recorded 
arm choices and latencies to reach the food cup in the first arm chosen 
and the total time required to complete the daily trial. 
Morris Water Maze Task 
After completion of the radial-arm maze test, mice were provided with 
food ad libitum and 1 week later were tested on the standard Morris 
water maze (Morris, 1981) paradigm. The water maze was a large 
white plastic tank 180 cm in diameter and 54 cm in height. The pool 
was filled with 20 cm of water at room temperature (22°C), rendered 
opaque by adding one can of white powder paint. The submerged 
invisible escape platform was 19 cm in diameter. On top of the platform 
was a piece of metal mesh measuring 15 cm x 15 cm. The testing 
room had ample spatial cues taped to the walls. Swimming behavior 
was recorded by a video camera mounted on the ceiling across the 
pool that measured the path length and the time taken by each mouse 
to find the hidden platform for each trial, 
Spatial abilities were assessed in four distinct phases. In the first 
phase, mice were given four to six trials per day (16 trials in total), 
with an intertrial interval of 4-5 rain. At the start of each trial, the mouse 
was placed in the pool at one of four release points (north, south, east, 
or west), and it swam until it found the hidden platform located in the 
center of the northwest quadrant or until 120 s had elapsed. Failure 
to locate the submerged platform in the allotted time resulted in the 
mouse being placed on the platform for 15 s, after which it was returned 
to its home cage. The release point order was randomized. When the 
mice demonstrated symtotic performance during the four trials on day 
3, the mice were given a 60 s memory probe trial with the platform 
removed from the pool. In the second phase, the amount of time spent 
in each quadrant of the pool was calculated along with the number 
of crossings over the platform site. The third phase (days 4 and 5, 
consisting of six and four trials, respectively) tested mutant mice for 
reverse spatial strategy by swimming directly to the platform, reposi- 
tioned in the southeast location. In the fourth phase, a second memory 
probe trial was performed in which the platform was again removed 
from the pool and the percentage of time spent in each quadrant was 
measured, along with the number of crossings over the platform site. 
Data Analysis 
Statistical analyses employed 2-factor between/within design analysis 
of variance (ANOVA) and 1-factor ANOVA for simple main effects. For 
the probe trials of the water maze experiment, Tukey's post hoc tests 
were used to determine in which quadrants of the pool animals spent 
significantly more time. All values reported in the text and figures are 
expressed as means _+ SEMs. 
Histology and Morphometry of Brains of Mice Heterozygous 
for the Hdh °xs Mutation 
Brains from two heterozygous mice and two wild-type controls were 
examined at 4 months of age. Mice were anesthetized by an i ntraperito- 
neal injection of sodium pentobarbital (80 mg/kg) and perfused through 
the ascending aorta with a fixative solution containing 4% paraformal- 
dehyde and 1% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4) 
at a perfusion pressure of 120 mm/Hg ° for 60 min. The brains were 
removed, weighed, and placed in additional fixative solution for 24 hr. 
The brains were bisected in the midline, and serial frozen sections 
were cut at 30 i~m in the transverse plane throughout the entire length 
of the right half of each brain. Every second section in this series was 
mounted on chrome alum gelatin-coated slides and stained for Nissl 
substance using 0.10/o thionin in 0.1 M acetate buffer (pH 3.7). 
All histological sections were coded to prevent experimenter bias 
during the morphometric analyses. The individual volumes of the cau- 
date/putamen, globus pallidus, subthalamic nucleus, substantia nigra 
(i.e., both the pars compacta and the pars reticulata), and hippocam- 
pus were measured on the serial Nissl sections in millimeters cubed. 
Individual sections were visualized at a final magnification of 48 x,  
and the area of each nucleus was measured in square millimeters 
using an image analysis system (Bioquant System IV, RandM Biomet- 
rics). The volume was calculated from 
V= ~;A xTx  2, 
where E;A is the sum of area measurements, T is section thickness, 
and 2 is the periodicity of the section sample. 
Measurements of the numerical density of neurons (Nv; neurons per 
millimeter cubed) were made in the caudate/putamen, globus paUidus, 
subthalamic nucleus, and substantia nigra using the methodology of 
Abercrombie (1946). In brief, sections were examined at a final magnifi- 
cation of 1025 x. Neurons were counted when their nuclear profiles 
contained a distinct nucleolus. The Nv was calculated from 
Nv = NA/(D + r), 
where NA is the number of neurons per unit area of section, D is the 
mean diameter of the nucleolus, and T is section thickness. The total 
number of neurons for each nucleus was calculated using estimates 
of Nv and volume. For individual neurons, the profile areas of the cell 
Cell 
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body were measured in the plane of focus that contained the nucleolus 
from 100 randomly selected neurons in each nucleus. The statistical 
significance of direct comparisons between heterozygous mice and 
wild-type controls was determined using the Student's t test. 
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